Template:Nasopharyngeal carcinoma: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''N...") |
Homa Najafi (talk | contribs) No edit summary |
||
| (5 intermediate revisions by 4 users not shown) | |||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma (patient information)|Patient | [[Nasopharyngeal carcinoma (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
| Line 29: | Line 29: | ||
! | ! | ||
[[Nasopharyngeal carcinoma historical perspective|Historical Perspective]] | [[Nasopharyngeal carcinoma historical perspective|Historical Perspective]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Nasopharyngeal carcinoma classification|Classification]] | |||
|- | |- | ||
! | ! | ||
| Line 40: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma | [[Nasopharyngeal carcinoma causes|Causes]] | ||
|- | |- | ||
! | ! | ||
| Line 46: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma | [[Nasopharyngeal carcinoma differential diagnosis|Differentiating Nasopharyngeal carcinoma from other Diseases]] | ||
|- | |- | ||
! | ! | ||
| Line 52: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma | [[Nasopharyngeal carcinoma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
| Line 58: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma | [[Nasopharyngeal carcinoma risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
| Line 64: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma | [[Nasopharyngeal carcinoma screening|Screening]] | ||
|- | |- | ||
! | ! | ||
| Line 70: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Nasopharyngeal carcinoma natural history|Natural History, Complications | [[Nasopharyngeal carcinoma natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
| Line 77: | Line 83: | ||
! | ! | ||
Diagnosis | Diagnosis | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Nasopharyngeal carcinoma diagnostic study of choice|Diagnostic Study of Choice]] | |||
|- | |- | ||
! | ! | ||
| Line 82: | Line 95: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Nasopharyngeal carcinoma history and symptoms|History | [[Nasopharyngeal carcinoma history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
| Line 94: | Line 107: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Nasopharyngeal carcinoma laboratory | [[Nasopharyngeal carcinoma laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 149: | Line 162: | ||
! | ! | ||
[[Nasopharyngeal carcinoma medical therapy|Medical Therapy]] | [[Nasopharyngeal carcinoma medical therapy|Medical Therapy]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Nasopharyngeal carcinoma interventions|Interventions]] | |||
|- | |- | ||
! | ! | ||
| Line 181: | Line 200: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Nasopharyngeal carcinoma case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " | ||
Latest revision as of 15:35, 13 March 2019
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma |